Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
13.99
-0.75 (-5.09%)
Mar 6, 2026, 12:58 PM EST - Market open
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,211,367
Profits / Employee
$2,243,766
Market Cap
1.86B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 800 |
| Ascentage Pharma Group International | 605 |
| Syndax Pharmaceuticals | 298 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Stoke Therapeutics | 128 |
AUPH News
- 7 days ago - Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets - Benzinga
- 7 days ago - Aurinia Pharmaceuticals Inc. (AUPH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Business Wire
- 15 days ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - Business Wire
- 4 months ago - Aurinia Pharmaceuticals Inc. (AUPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Business Wire
- 4 months ago - Wall Street Breakfast Podcast: FDA Executive Controversy - Seeking Alpha
- 4 months ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - Business Wire